Angkasekwinai, N.; Rattanaumpawan, P.; Chayakulkeeree, M.; Phoompoung, P.; Koomanachai, P.; Chantarasut, S.; Wangchinda, W.; Srinonprasert, V.; Thamlikitkul, V.
Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study. Antibiotics 2022, 11, 796.
https://doi.org/10.3390/antibiotics11060796
AMA Style
Angkasekwinai N, Rattanaumpawan P, Chayakulkeeree M, Phoompoung P, Koomanachai P, Chantarasut S, Wangchinda W, Srinonprasert V, Thamlikitkul V.
Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study. Antibiotics. 2022; 11(6):796.
https://doi.org/10.3390/antibiotics11060796
Chicago/Turabian Style
Angkasekwinai, Nasikarn, Pinyo Rattanaumpawan, Methee Chayakulkeeree, Pakpoom Phoompoung, Pornpan Koomanachai, Sorawit Chantarasut, Walaiporn Wangchinda, Varalak Srinonprasert, and Visanu Thamlikitkul.
2022. "Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study" Antibiotics 11, no. 6: 796.
https://doi.org/10.3390/antibiotics11060796
APA Style
Angkasekwinai, N., Rattanaumpawan, P., Chayakulkeeree, M., Phoompoung, P., Koomanachai, P., Chantarasut, S., Wangchinda, W., Srinonprasert, V., & Thamlikitkul, V.
(2022). Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study. Antibiotics, 11(6), 796.
https://doi.org/10.3390/antibiotics11060796